W. B. Stone

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection

Lucía B. Chemes, D. Alvarez, Julieta Alcain, 2021, bioRxiv.

Novel murine models for studying Cache Valley virus pathogenesis and in utero transmission

S. Paulson, Jesse H. Erasmus, A. J. Auguste, 2021, Emerging microbes & infections.

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice

D. Alvarez, Julieta Alcain, J. Cassataro, 2022, Frontiers in Immunology.

A hepatitis B virus core antigen‐based virus‐like particle vaccine expressing SARS‐CoV‐2 B and T cell epitopes induces epitope‐specific humoral and cell‐mediated immune responses but confers limited protection against SARS‐CoV‐2 infection

D. Tian, I. C. Allen, Harini Sooryanarain, 2023, Journal of medical virology.

The influence of SARS‐CoV‐2 infection on expression of drug‐metabolizing enzymes and transporters in a hACE2 murine model

K. Deshpande, B. Firestein, C. Yohn, 2023, Pharmacology research & perspectives.

Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants

L. I. Ibañez, G. Marcoppido, A. Wigdorovitz, 2023, bioRxiv.